Published in Clin Exp Immunol on July 01, 1973
In vitro synthesis of lysozyme by human and mouse tissues and leucocytes. Immunology (1975) 1.64
In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immunology (1975) 1.50
Immune complexes in skin of NZB/NZW mice. Clin Exp Immunol (1975) 1.18
Neisseria meningitidis lactate permease is required for nasopharyngeal colonization. Infect Immun (2005) 1.11
In vitro synthesis of immunoglobulins, secretory component, complement and lysozyme by human gastrointestinal tissues. I. Normal tissues. Clin Exp Immunol (1976) 0.99
Serum immunoglobulin levels in various skin diseases. Clin Exp Immunol (1974) 0.96
Lacrimal immunoglobulins and complement quantified by counter-immunoelectrophoresis. Br J Ophthalmol (1975) 0.94
In vitro synthesis of humoral factors (immunoglobulins and complement) in lesional skin of leprosy patients. Infect Immun (1979) 0.93
Effect of host lactate on gonococci and meningococci: new concepts on the role of metabolites in pathogenicity. Infect Immun (2007) 0.90
In vitro synthesis of anti-mycobacterial antibodies in biopsies from skin lesions of leprosy patients. Infect Immun (1980) 0.84
Human seminal plasma inhibition of antibody complement-mediated killing and opsonization of Neisseria gonorrhoeae and other gram-negative organisms. J Clin Invest (1981) 0.78
Immunological study of keratoacanthomas. Arch Dermatol Res (1980) 0.75
Immunological processes involving the oral mucosa in lichen planus. Proc R Soc Med (1976) 0.75
Antimicrobial factors in the exudates of skin windows in human subjects. Clin Exp Immunol (1976) 0.75
Serum IgE-concentrations in patients with contact sensitization. Arch Dermatol Res (1975) 0.75
Extreme hypercomplementemia in the setting of mixed cryoglobulinemia. Clin Rheumatol (2011) 0.75
[A micro-method of immuno-electrophoresis]. Int Arch Allergy Appl Immunol (1955) 52.23
THE NORMAL HUMAN INTESTINAL MUCOSA AS A MAJOR SOURCE OF PLASMA CELLS CONTAINING GAMMA-A-IMMUNOGLOBULIN. Lab Invest (1965) 5.31
The distribution of immunoglobulin-containing cells along the human gastrointestinal tract. Gastroenterology (1966) 3.98
GAMMA-GLOBULINS: QUANTITATIVE RELATIONSHIPS IN HUMAN SERUM AND NONVASCULAR FLUIDS. Science (1963) 3.88
The human secretory immunoglobulin system: immunohistoligical localization of gamma A, secretory "piece," and lactoferrin in normal human tissues. J Exp Med (1969) 3.08
The formation of immunoglobulins by human tissues in vitro. I. The methods and their specificity. Immunology (1966) 2.83
Immunoglobulin-containing cells in the intestinal mucosa and immunoglobulins in the intestinal juice in children. Clin Exp Immunol (1972) 2.34
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
Immunoglobulin production in bronchial mucosa and bronchial lymph nodes, particularly in cystic fibrosis of the pancreas. J Immunol (1968) 2.12
Localization of 11 S external secretory IgA by immunofluorescence in tissues lining the oral and respiratory passages in man. J Immunol (1968) 2.04
THE APPLICATION OF THE FLUORESCENT ANTIBODY TECHNIC TO THE INVESTIGATION OF LUPUS ERYTHEMATOSUS AND VARIOUS DERMATOSES. J Invest Dermatol (1963) 1.95
Immunoglobulin-containing cells in normal jejunal mucosa and in ulcerative colitis and regional enteritis. Scand J Gastroenterol (1969) 1.88
Secretory IgA in the serum. Lancet (1969) 1.84
"BOUND" GLOBULIN IN THE SKIN OF PATIENTS WITH CHRONIC DISCOID LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS. Lancet (1964) 1.70
Distribution of immunoglobulins in human rectal mucosa. I. Normal control subjects. Gastroenterology (1968) 1.67
In vitro combination of human and bovine free secretory component with IgA of various species. Nature (1970) 1.59
"BOUND" COMPLEMENT IN THE SKIN OF PATIENTS WITH CHRONIC DISCOID LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS. Lancet (1964) 1.52
Immunoglobulin and specific antibody synthesis in a chronic inflammatory focus: antigen-induced synovitis. J Immunol (1969) 1.52
Immunoglobulin A: localization in rectal mucosal epithelial cells. Science (1967) 1.47
The complement system of man (second of four parts). N Engl J Med (1972) 1.47
Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis. An immunofluorescent study. Br J Dermatol (1969) 1.46
Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol (1971) 1.39
Localization of immunoglobulins in human nasal mucosa. Immunochemistry (1967) 1.37
Study of cutaneous lupus erythematosus by immunohistochemical methods. Arch Dermatol (1968) 1.29
The human female reproductive tract: immunohistological localization of gamma A, gamma G, gamma M, secretory "piece," and lactoferrin. Am J Obstet Gynecol (1970) 1.28
The formation of immunoglobulins by human tissues in vitro. II. Quantitative studies. Immunology (1966) 1.23
Studies on human secretory IgA comparative studies of the IgA-bound secretory piece and the free secretory piece protein. Immunochemistry (1971) 1.23
Stabilization of dissociable IgA2 proteins by secretory component. J Immunol (1972) 1.20
Discoid lupus erythematosus. Electron microscopic studies of paramyxovirus-like structures. Arch Dermatol (1970) 1.14
Binding of secretory piece to polymeric IgA and IgM paraproteins in vitro. Immunology (1971) 1.12
The presence of complement "bound" in vivo in the skin of patients with pemphigoid. Dermatologica (1968) 1.12
AUTOIMMUNITY AND PERIODONTAL DISEASE. Odontol Tidskr (1965) 1.10
Reduction and proteolytic degradation of immunoglobulin A from human colostrum. Acta Chem Scand (1966) 1.06
Immunopathologic investigations in lupus erythematosus. J Invest Dermatol (1969) 1.05
IgD in various dermatoses; immunofluorescence studies. Br J Dermatol (1971) 1.03
Pemphigus antibodies: their role in disease. J Invest Dermatol (1971) 1.00
Classification of immunoglobulins in the dermo-epidermal junction in lupus erythematosus. Clin Exp Immunol (1966) 1.00
[Ultrastructural study of the skin in 42 cases of lupus erythematosus]. Presse Med (1970) 0.95
The occurrence of certain serum factors in the dermal-epidermal junction and vessel walls of the skin in lupus erythematosus and other (skin) diseases. Acta Derm Venereol (1968) 0.95
Isolation of free secretory component (S.C.) from human milk, determination of its molecular weight. Immunochemistry (1971) 0.85
The molecular weight and the amino acid and carbohydrate compositions of free secretory component (SC). Immunology (1972) 0.83
Immunofluorescence patterns in dermatitis herpetiformis. Investigations on skin and intestinal mucosa. Br J Dermatol (1971) 0.82
[Ultrastructural aspects of virus-like inclusions in the skin of Lupus erythematosus acutus and chronicus]. Arch Dermatol Forsch (1971) 0.80
[Presence and synthesis of immunoglobulins in tissues of the gastro-intestinal and respiratory tracts, in the conjuctival and vaginal mucosa and in the skin]. Prog Immunobiol Stand (1970) 0.78
The origin and kinetics of mononuclear phagocytes. J Exp Med (1968) 14.96
Morphology and peroxidase cytochemistry of mouse promonocytes, monocytes, and macrophages. J Exp Med (1970) 4.26
The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ (1972) 4.25
The effect of glucocorticosteroids on the kinetics of mononuclear phagocytes. J Exp Med (1970) 4.09
Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state. J Exp Med (1979) 3.57
Identification and characterization of the monoblast in mononuclear phagocyte colonies grown in vitro. J Exp Med (1975) 3.53
Nitric oxide: a predictor of morbidity in postoperative patients? Lancet (1994) 3.26
Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10. J Infect Dis (1985) 3.16
The kinetics of promonocytes and monocytes in the bone marrow. J Exp Med (1970) 3.12
Origin and kinetics of monocytes and macrophages. Semin Hematol (1970) 2.92
The formation of immunoglobulins by human tissues in vitro. I. The methods and their specificity. Immunology (1966) 2.83
Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax (1995) 2.54
The immunological development of the human fetus. J Exp Med (1965) 2.44
Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. J Clin Invest (1979) 2.42
The formation of immunoglobulins by human tissues in vitro. IV. Circulating lymphocytes in normal and pathological conditions. Immunology (1966) 2.40
The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state. J Exp Med (1978) 2.29
Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect Immun (1977) 2.23
The effect of glucocorticosteroids on the proliferation and kinetics of promonocytes and monocytes of the bone marrow. J Exp Med (1973) 2.01
Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium. J Immunol (1987) 1.92
Characteristics of human mononuclear phagocytes. Blood (1979) 1.88
Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin Infect Dis (1992) 1.86
Quantitative studies on the dispersal of skin bacteria into the air. J Med Microbiol (1976) 1.85
Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet (1984) 1.79
Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun (1981) 1.74
Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Immunology (1979) 1.73
High levels of interleukin 10 and tumor necrosis factor alpha in cerebrospinal fluid during the onset of bacterial meningitis. Clin Infect Dis (1995) 1.70
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. Antimicrob Agents Chemother (1989) 1.66
In vitro synthesis of lysozyme by human and mouse tissues and leucocytes. Immunology (1975) 1.64
Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS (1994) 1.61
In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med (1982) 1.56
Kinetics of intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Eur J Immunol (1980) 1.55
Origin and turnover of monocytes and macrophages. Curr Top Pathol (1989) 1.54
The formation of immunoglobulins by human tissues in vitro. 3. Spleen, lymph nodes, bone marrow and thymus. Immunology (1966) 1.53
Antimicrobial proteins of murine macrophages. Infect Immun (1993) 1.50
In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immunology (1975) 1.50
Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J Infect Dis (1981) 1.48
CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J Immunol (1991) 1.45
Cytokines and the host defense against Listeria monocytogenes and Salmonella typhimurium. Biotherapy (1994) 1.42
Macrophage activity and clinical immunology. Origin and kinetics of mononuclear phagocytes. Ann N Y Acad Sci (1976) 1.41
Effect of warfarin on the induction and course of experimental endocarditis. Infect Immun (1976) 1.40
[Bacterial meningitis; pathogenesis and current possibilities of additional therapy]. Ned Tijdschr Geneeskd (1992) 1.40
Monocyte adherence to human vascular endothelium. J Leukoc Biol (1993) 1.38
[Immune response following preventive intracutaneous rabies vaccination]. Ned Tijdschr Geneeskd (1991) 1.38
Exclusive occurrence of K chains in isolated cold haemagglutinins. Scand J Haematol (1965) 1.38
Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages. J Leukoc Biol (1999) 1.35
Current view on the mononuclear phagocyte system. Immunobiology (1982) 1.35
Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1. Infect Immun (1990) 1.32
Infection of human vascular endothelial cells with Staphylococcus aureus induces hyperadhesiveness for human monocytes and granulocytes. J Immunol (1997) 1.31
Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages. J Immunol (1987) 1.31
Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis (1993) 1.29
Dual origin of mouse spleen macrophages. J Exp Med (1984) 1.28
Kinetics of phagocytosis and intracellular killing of Staphylococcus aureus and Escherichia coli by human monocytes. Scand J Immunol (1981) 1.27
Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract. Infect Immun (1999) 1.27
Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes. Infect Immun (1994) 1.27
Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice. Infect Immun (1992) 1.25
Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. Eur J Clin Microbiol Infect Dis (1988) 1.25
The use of lysostaphin in in vitro assays of phagocyte function: adherence to and penetration into granulocytes. Scand J Immunol (1981) 1.25
Culture of mononuclear phagocytes on a teflon surface to prevent adherence. J Exp Med (1978) 1.25
Properties of a factor increasing monocytopoiesis (FIM) occurring in serum during the early phase of an inflammatory reaction. Blood (1977) 1.24
The formation of immunoglobulins by human tissues in vitro. II. Quantitative studies. Immunology (1966) 1.23
Suspension cultures of mononuclear phagocytes in the teflon culture bag. Cell Immunol (1979) 1.23
Proliferative characteristics of monoblasts grown in vitro. J Exp Med (1975) 1.22
Role of granulocytes in experimental Streptococcus sanguis endocarditis. Infect Immun (1982) 1.22
Effect of thioglycolate on phagocytic and microbicidal activities of peritoneal macrophages. Infect Immun (1984) 1.22
Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine (2000) 1.22
Quantitative immunocytochemical characterization of mononuclear phagocytes. II. Monocytes and tissue macrophages. Immunology (1987) 1.21
Role of Yops in inhibition of phagocytosis and killing of opsonized Yersinia enterocolitica by human granulocytes. Infect Immun (1995) 1.19
Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun (1996) 1.19
A quantitative evaluation of pulmonary macrophage kinetics. Cell Tissue Kinet (1983) 1.19
Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intravenous administration of heat-killed bacillus Calmette-Guérin. J Exp Med (1981) 1.19
Ultrastructure of mononuclear phagocytes developing in liquid bone marrow cultures. A study on peroxidatic activity. J Exp Med (1979) 1.17
Role of granulocytes and monocytes in experimental Staphylococcus epidermidis endocarditis. Infect Immun (1983) 1.16
The formation in vitro of paraproteins in multiple myeloma and Waldenström's macroglobulinaemia. Br J Haematol (1966) 1.15
IgM-IgG cryoglobulinaemia with IgM paraprotein component. Clin Exp Immunol (1968) 1.15
Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study. J Infect Dis (1983) 1.13
Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults. Vaccine (2000) 1.13
The incidence of PUVA-induced freckles. Dermatologica (1984) 1.12
Method to prove investigation of particles by macrophages with light microscopy. Scand J Immunol (1980) 1.12
Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis (1995) 1.11
Humoral regulation of monocytopoiesis during the early phase of an inflammatory reaction caused by particulate substances. Blood (1977) 1.10
Origin and kinetics of Kupffer cells during an acute inflammatory response. Immunology (1979) 1.10
Clinical infections and nonsurgical treatment of parapharyngeal space infections complicating throat infection. Rev Infect Dis (1990) 1.09
Activation of mouse peritoneal macrophages during infection with Salmonella typhimurium does not result in enhanced intracellular killing. J Immunol (1990) 1.09
A serum facted by newborn calf serum. Cell Tissue Kinet (1976) 1.09
Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins. Antimicrob Agents Chemother (1991) 1.09
Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb. J Immunol (1982) 1.08
Scleromyxoedema (lichen myxoedematosus) associated with a paraprotein, IgG 1 of type kappa. Br J Dermatol (1973) 1.07
Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations. Eur J Clin Microbiol Infect Dis (1991) 1.07
Differences in the response of inbred mouse strains to the factor increasing monocytopoiesis. J Exp Med (1984) 1.07
Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo. Antimicrob Agents Chemother (1990) 1.06
Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use. J Infect Dis (1984) 1.06
Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases. J Immunol (1995) 1.05
Heat shock protein 65 induces CD62e, CD106, and CD54 on cultured human endothelial cells and increases their adhesiveness for monocytes and granulocytes. J Immunol (1996) 1.05
Characterization of monocyte adherence to human macrovascular and microvascular endothelial cells. J Immunol (1990) 1.04
Role of YadA in resistance to killing of Yersinia enterocolitica by antimicrobial polypeptides of human granulocytes. Infect Immun (1996) 1.04
Differences in initial rate of intracellular killing of Salmonella typhimurium by resident peritoneal macrophages from various mouse strains. J Immunol (1985) 1.04
Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction. Inflammation (1989) 1.04
Quantitative effect of granulocytes on antibiotic treatment of experimental staphylococcal infection. Antimicrob Agents Chemother (1987) 1.03